RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.

about

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype.

Item

http://www.wikidata.org/entity/Q50029763

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@en

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@nl

type

Item

label

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@en

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@nl

prefLabel

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@en

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@nl

P1476

RTS,S malaria vaccine efficacy ...... associated with HLA genotype.

@en

P2093

C F Ockenhouse

http://www.w3.org/2001/XMLSchema#string

C M Nielsen

http://www.w3.org/2001/XMLSchema#string

J A Regules

http://www.w3.org/2001/XMLSchema#string

J Vekemans

http://www.w3.org/2001/XMLSchema#string

K E Kester

http://www.w3.org/2001/XMLSchema#string

M Lievens

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)

High-resolution HLA alleles and haplotypes in the United States population

Common west African HLA antigens are associated with protection from severe malaria

No adjustments are needed for multiple comparisons

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases.

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study.

Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

P304

1637-1642

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.VACCINE.2018.01.069

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29439870

http://www.w3.org/2001/XMLSchema#string

P921

malaria

Plasmodium falciparum

P932

5843576

http://www.w3.org/2001/XMLSchema#string